Meet Lophius at the virtual 46th Annual Meeting of the EBMT
In light of the COVID-19 pandemic, the EBMT board has made the decision to hold the 46th annual meeting of the European Society for Blood and Marrow Transplantation (EBMT), as a virtual Edition.
Lophius recently published successful top-line results from its multicenter AlloProtect CMV clinical study in hematopoietic stem cell transplant recipients.
We would be delighted to invite you to visit our scientific E-poster presentation, taking place on September 1st in the virtual E-poster gallery:
B132 "Standardized monitoring of cytomegalovirus-specific cellular immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation" Wagner-Drouet et al.
B109 "Comparison of immune cell response to cytomegalovirus proteins versus peptides using an IFNγ ELISpot assay to monitor cytomegalovirus-specific immunity after hematopoietic stem cell transplantation" Wagner-Drouet et al.
Interested to learn more about the capabilities of our CE-marked T-Track® CMV test in the field of hematopoietic stem cell transplantation? You are welcome to chat with Dr. Figen Beceren-Braun and Dr. Traudel Schmidt at our virtual booth at the exhibition.
The virtual booth will be available for viewing both during the live event days and for 2 months following the meeting.